Does BIS-Monitoring influence the demand of sedative medication during open muscle biopsies under analgosedation in children?

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00005022

Enrollment

Registered

2013-05-23

Start date

2013-06-07

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G72.9

Interventions

Group 1: Group A no additional BIS monitoring Group 2: Group B additional BIS Monitoring

Eligibility

Sex/Gender

All

Age

6 Months to 18 Years

Inclusion criteria

Inclusion criteria: Muscle biopsy necessary

Exclusion criteria

Exclusion criteria: no written informed consent putting the patient at risk by sedation without intubation intolerance for used medication structural malformation of the brain

Design outcomes

Primary

Measure	Time frame
amount of sedative medication needed	—

Secondary

Measure	Time frame
Time until eye opening after intervention Incidence of adverse effects	—

Countries

Germany

Contacts

Public ContactEva Tschiedel

Universitätsklinik Essen Klinik für Kinderheilkunde 1

eva.tschiedel@uk-essen.de0201/7232251

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026